» Articles » PMID: 17393525

Value of the Critical Flicker Frequency in Patients with Minimal Hepatic Encephalopathy

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2007 Mar 30
PMID 17393525
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Minimal hepatic encephalopathy (MHE) is mainly diagnosed using psychometric tests such as the psychometric hepatic encephalopathy score (PHES). Despite the clinical and social relevance of MHE, psychometric testing is not widespread in routine clinical care. We assessed the usefulness of the critical flicker frequency (CFF), for the diagnosis of MHE and for the prediction of the development of overt episodes of HE. The normal range of PHES in the Spanish population was evaluated in a control group. Subsequently, 114 patients with cirrhosis and 103 healthy controls underwent both PHES and CFF tests. A diagnosis of MHE was made when the PHES was lower than -4 points. Patients were followed-up every 6 months for a total of 1 year. CFF did not correlate with age, education, or sex in the control group. The mean CFF was significantly lower in patients with MHE versus non-MHE or controls. Mean CFF correlated with individual psychometric tests as well as PHES (r = 0.54; P < 0.001). CFF <38 Hz was predictive of further bouts of overt HE (log-rank: 14.2; P < 0.001). There was a weak correlation between mean CFF and Child-Pugh score but not with model for end-stage liver disease score. In multivariate analysis using Cox regression, CFF together with Child-Pugh score was independently associated with the development of overt HE.

Conclusion: CFF is a simple, reliable, and accurate method for the diagnosis of MHE. It is not influenced by age or education and could predict the development of overt HE.

Citing Articles

Bibliometrics and knowledge mapping of the pathogenesis of hepatic encephalopathy in patients with liver cirrhosis.

Wu S, Li L, Xi H, Wu X, He Y, Sun X Heliyon. 2024; 10(15):e34330.

PMID: 39145014 PMC: 11320160. DOI: 10.1016/j.heliyon.2024.e34330.


Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop-CN model (NCRCID-CHESS 2106): a prospective multicenter study.

Li X, Liu S, Guo Y, Zu H, Xiang H, Yang S MedComm (2020). 2024; 5(8):e627.

PMID: 39015557 PMC: 11247336. DOI: 10.1002/mco2.627.


Preface for the Vicente Felipo Honorary Issue of Neurochemical Research.

Llansola M Neurochem Res. 2024; 49(6):1421-1426.

PMID: 38641758 DOI: 10.1007/s11064-024-04139-3.


EncephalApp Stroop Test for covert hepatic encephalopathy screening in Tunisian cirrhotic patients.

Hamzaoui L, Mahmoudi M, Mohamed G, Elloumi H, Laabidi A, Boubaker J F1000Res. 2023; 11:686.

PMID: 37767072 PMC: 10521086. DOI: 10.12688/f1000research.121781.2.


Hepatic Encephalopathy following Transjugular Intrahepatic Portosystemic Shunt Placement.

Thornburg B Semin Intervent Radiol. 2023; 40(3):262-268.

PMID: 37484451 PMC: 10359131. DOI: 10.1055/s-0043-1769770.